Joshua Rousseau

Materials ScienceBiochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyEngineeringMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Lesion-specific suppression of YAP/TAZ by biomimetic nanodrug ameliorates atherosclerosis development”.

Lesion-specific suppression of YAP/TAZ by biomimetic nanodrug ameliorates atherosclerosis development

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.24.537992

N/A

0DataRank · unranked

3 citations

Ting‐Yun Wang, Joshua Rousseau, Michelle Mungaray, Chamonix Michaud, Christopher Plaisier +3 more

Biomimetic nanodrug targets inflammation and suppresses YAP/TAZ to ameliorate atherosclerosis

Biomaterials(2024)10.1016/j.biomaterials.2024.122505

N/A

0DataRank · unranked

32 citations

Ting‐Yun Wang, Joshua Rousseau, M. Orlando, Michelle Mungaray, Chamonix Michaud +4 more

Monocyte‐Mimetic Contrast Agent Enables Targeted and Sensitive Magnetic Resonance Imaging of Atherosclerotic Lesions

Advanced Healthcare Materials(2025)10.1002/adhm.202502001

N/A

0DataRank · unranked

3 citations

Ting‐Yun Wang, Samantha McClendon, Dakota Ortega, M. Orlando, Scott C. Beeman +3 more